Aranesp, Procrit Potential Role In Tumor Proliferation Subject Of FDA Committee Review

Studies have raised questions about the angiogenic potential of erythropoietin and its role in tumor hypoxia. Oncologic Drugs Advisory Committee is not expected to address cases of pure red blood cell aplasia.